Tirzepatide

Dual GIP / GLP-1 receptor agonist studied in metabolic research models.

Select size

Qty

Total

$165.00

Purity: ≥ 99%
Mol. weight: 4813.450 Da
Sequence: Modified GIP/GLP-1 hybrid
Storage: Lyophilized: -20 °C, light-protected. Reconstituted: 2–8 °C, use within 30 days.

About

Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist. It is studied in vitro for incretin-pathway co-activation, beta-cell signaling, and metabolic research applications.

Research-use only

Sold strictly for in-vitro laboratory research. Not for human or veterinary consumption, diagnostic, or therapeutic use. See our research-use terms.

Batch & COA

Recent batches

No batches uploaded yet — every shipped vial will include the corresponding COA, also searchable at /coa.